Symbiotiq ApS: Financial statements 2023
CVR: 42741809
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Symbiotiq ApS (CVR 42741809) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,458,107 and a net result of DKK 898,015. Equity in the 2023 report amounted to DKK 1,460,686. The solvency ratio was 64.2%.
- Gross Profit
- DKK 1,458,107
- Profit/Loss
- DKK 898,015
- Equity
- DKK 1,460,686
- Total Assets
- DKK 2,274,885
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Symbiotiq ApS has published its interim report for the period September 29, 2021 to December 31, 2022.
About Symbiotiq ApS
Symbiotiq ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Bonde. The company is owned by Mads Bonde. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. Equity in the 2025 report amounted to DKK 2,077,864.